J2260 HCPCS code: Injection, milrinone lactate, 5 mg
J2260 is the HCPCS Level II code for injection, milrinone lactate, 5 mg. In 2024 Medicare paid an average of $1.14 per service for J2260 across 1,928,791 services. Its Medicare coverage code is D (Special coverage instructions apply): May be covered when national or local coverage criteria are met. The NCCI unit limit is 252 per day on DME suppliers. Medicare volume fell 19% from 2022 to 2024 (2,392,717 to 1,928,791 services). In 2024, 265 suppliers billed Medicare for J2260 (purchases), serving 1,663 beneficiaries; New Jersey, Texas, Pennsylvania accounted for 39% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1986-01-01 |
| Last action effective | 2018-01-01 |
Who bills J2260 (2024)
| Measure | Value |
|---|---|
| Suppliers billing rentals | — |
| Suppliers billing purchases | 265 |
| Referring clinicians | 1,295 |
| Medicare beneficiaries | 1,663 |
| States with claims | 43 |
| Share of services in top 3 states (New Jersey, Texas, Pennsylvania) | 39% |
| Year | Suppliers | Beneficiaries |
|---|---|---|
| 2022 | 330 | 2,052 |
| 2023 | 283 | 1,944 |
| 2024 | 265 | 1,663 |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2260, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 2,392,717 | 2,052 | $1.68 | $1.32 |
| 2023 | 2,193,306 | 1,944 | $1.91 | $1.49 |
| 2024 | 1,928,791 | 1,663 | $1.46 | $1.14 |
States with the most J2260 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New Jersey | 342,970 | $1.15 |
| Texas | 261,717 | $1.15 |
| Pennsylvania | 141,141 | $1.15 |
| Florida | 126,368 | $1.15 |
| New York | 108,092 | $1.15 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 252 | Clinical: Data |
| outpatient hospital claims | 16 | Clinical: Data |
| practitioner claims | 4 | Clinical: Data |
What changed for J2260
- 1986-01-01: J2260 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2260?
J2260 is the HCPCS Level II code for injection, milrinone lactate, 5 mg. Short descriptor: "Inj milrinone lactate / 5 mg".
How much does Medicare pay for J2260?
In 2024, the average Medicare payment was $1.14 per service (average allowed $1.46).
Does Medicare cover J2260?
Coverage code D — Special coverage instructions apply. May be covered when national or local coverage criteria are met.
How many units of J2260 can be billed per day?
252 on DME suppliers; 16 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related J22 codes
- J2210 — Injection, methylergonovine maleate, up to 0.2 mg
- J2212 — Injection, methylnaltrexone, 0.1 mg
- J2246 — Injection, micafungin in sodium (baxter), not therapeutically equivalent to j2248, 1 mg
- J2247 — Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
- J2248 — Injection, micafungin sodium, 1 mg
- J2249 — Injection, remimazolam, 1 mg
- J2250 — Injection, midazolam hydrochloride, per 1 mg
- J2251 — Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2252 — Injection, midazolam in 0.8% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
- J2253 — Injection, midazolam (seizalam), 1 mg
- J2265 — Injection, minocycline hydrochloride, 1 mg
- J2267 — Injection, mirikizumab-mrkz, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2260
- Watch J2260 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2260
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.